These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 18771008)
21. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release. Hu FQ; Wu MZh; Yuan H; Zhang HH Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749 [TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Zhu RR; Qin LL; Wang M; Wu SM; Wang SL; Zhang R; Liu ZX; Sun XY; Yao SD Nanotechnology; 2009 Feb; 20(5):055702. PubMed ID: 19417361 [TBL] [Abstract][Full Text] [Related]
23. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Mukherjee S; Ray S; Thakur RS Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221 [TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Lee MK; Lim SJ; Kim CK Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668 [TBL] [Abstract][Full Text] [Related]
25. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112 [TBL] [Abstract][Full Text] [Related]
26. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216 [TBL] [Abstract][Full Text] [Related]
27. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254 [TBL] [Abstract][Full Text] [Related]
28. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874 [TBL] [Abstract][Full Text] [Related]
29. [Preparation and liver targeting of floxuridinyl dibutyrate solid lipid nanoparticles]. Li JJ; Yang GD; Wang HY; Zhang SQ Yao Xue Xue Bao; 2008 Jul; 43(7):761-5. PubMed ID: 18819483 [TBL] [Abstract][Full Text] [Related]
30. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
31. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles. Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535 [TBL] [Abstract][Full Text] [Related]
32. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992 [TBL] [Abstract][Full Text] [Related]
33. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636 [TBL] [Abstract][Full Text] [Related]
34. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Rahman Z; Zidan AS; Khan MA Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882 [TBL] [Abstract][Full Text] [Related]
35. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer. Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471 [TBL] [Abstract][Full Text] [Related]
36. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. Ding D; Zhu Z; Li R; Li X; Wu W; Jiang X; Liu B ACS Nano; 2011 Apr; 5(4):2520-34. PubMed ID: 21428432 [TBL] [Abstract][Full Text] [Related]
37. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. Sharma P; Ganta S; Denny WA; Garg S Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127 [TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Hu L; Tang X; Cui F J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759 [TBL] [Abstract][Full Text] [Related]
39. [Targeted distribution of cis-platin magnetic nanoparticles in mice]. Zhang HZ; Xie MQ; Kang Z; Shen H; Wang L Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1756-9. PubMed ID: 18971164 [TBL] [Abstract][Full Text] [Related]
40. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]